[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 28, Issue 1 (spring 2018) ::
MEDICAL SCIENCES 2018, 28(1): 24-30 Back to browse issues page
Cardioprotective effects of quercetin on doxorubicin induced cardiotoxicity in male rats
Farzad Rahmani 1, Nasim Asar 1, Parvaneh Najafizadeh 2, Seyede Zahra Mousavi * 3, Tayebeh Rastegar 4
1- Herbal Medicines Research Center, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran-Iran (HMRC).
2- Assistant Professor Departent of Pharmacology, Faculty of Medicine, Iran University of Medical Sciences, Tehran-Iran.-Young Researchers & Elite Club, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran - Iran.
3- Associated Professor Department of Pharmacology & Toxicology, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran (IAUPS). -Associate professor, Herbal Pharmacology Research Center, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, IR Iran , mosavi50@yahoo.com
4- Assistant Professor Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (963 Views)
Background: Doxorubicin (Dox) is an effective anthracycline anticancer drug, although it’s clinical efficacy is restricted because of several acute and chronic side effects such as cardiotoxicity. The aim of this study was to investigate the cardioprotective effects of quercetin on doxorubicin induced toxicity in male rats.
Materials and methods: This experimental study was done on 30 Wistar rats, which divided into five groups (6 rats in each group). One control group was treated with saline (1 mL/kg), while the second control group (quercetin vehicle) received DMSO (1 mL/kg) for 14 days. Experimental groups were orally treated with quercetin every day at a dosage of 20 mg/kg, doxorubicin (25 mg/kg, i.p.) on 12th, 13th and 14th days of the experiment, as well as, with the combination of doxorubicin and Quercetin in stated doses. The treatment period lasted for 14 days. Body weight and histological preparations of heart samples of treated animals were examined on 15th day.
Results: Body weight animals treated with doxorubicin significantly decreased compared to other groups (p<0.05). Quercetin was able to prevent weight loss caused by doxorubicin. Histopathological findings revealed that pretreatment by quercetin had protective efficacy against doxorubicin induced cardiotoxicity.
Conclusion: According to pathological results, we confirmed that quercetin possess hepatoprotective effect against doxorubicin induced cardiotoxicity which may be through its antioxidant activity.
Keywords: Quercetin, Doxorubicin, Cardiotoxicity, Rat
Full-Text [PDF 775 kb]   (201 Downloads)    
Type of Study: Experimental | Subject: Pharmacology
Received: 2017/07/24 | Accepted: 2017/11/29 | Published: 2018/04/1
References
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90. [DOI:10.3322/caac.20107]
2. National Comprehensive Cancer Control Program, Department of Health, Department of Cancer Management Center noncommunicable diseases, Ministry of Health and Medical Education, 2014, [Persian].
3. Balducci L. Epidemiology of cancer and aging. J Oncol Manag 2005;14:47-50. [DOI:10.1007/0-387-23962-6_1]
4. According to the National Cancer Registry, Ministry of Health and Medical Education, Department of Health, 2009, Treatment of non-communicable diseases and cancer management, 2011, [Persian].
5. Li M, Xiong G. Ion channels as targets for cancer therapy. Int J Physiol Pathophysiol Pharmacol 2011;3:156-66.
6. Arcamone F, Cassinelli G, Fantini G, Grein A, Orezzi P, Pol C, et al. Adriamycin, 14‐Hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol Bioeng 2000;67:704-13. https://doi.org/10.1002/(SICI)1097-0290(20000320)67:6<704::AID-BIT8>3.0.CO;2-L [DOI:10.1002/(SICI)1097-0290(20000320)67:63.0.CO;2-L]
7. Di Marco A, Gaetani M, Scarpinato B. Adriamycin (NSC-123 127) a new antibiotic with antitumor activity. Cancer Chemother Rep 1969;53:33-7.
8. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973;32:302-14. https://doi.org/10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2 [DOI:10.1002/1097-0142(197308)32:23.0.CO;2-2]
9. Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozencweig M, et al. Risk factors for doxorubicin-lnduced congestive heart failure. Ann Intern Med 1979;91:710-7. [DOI:10.7326/0003-4819-91-5-710]
10. Kalender Y, Yel M, Kalender S. Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats: the effects of vitamin E and catechin. Toxicology 2005;209:39-45. [DOI:10.1016/j.tox.2004.12.003]
11. Saad SY, Najjar TA, Al-Rikabi AC. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 2001;43:211-8. [DOI:10.1006/phrs.2000.0769]
12. Injac R, Perse M, Boskovic M, Djordjevic-Milic V, Djordjevic A, Hvala A, et al. Cardioprotective effects of fullerenol C60 (OH) 24 on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm. Technol Cancer Res Treat 2008;7:15-25. [DOI:10.1177/153303460800700102]
13. Injac R, Perse M, Cerne M, Potocnik N, Radic N, Govedarica B, et al. Protective effects of fullerenol C 60 (OH) 24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials 2009;30:1184-96. [DOI:10.1016/j.biomaterials.2008.10.060]
14. Zolfagharzadeh F, Roshan VD. Pretreatment hepatoprotective effect of regular aerobic training against hepatic toxicity induced by doxorubicin in rats. Asian Pac J Cancer Prev 2013;14:5227-32. [DOI:10.7314/APJCP.2013.14.5.2931]
15. Kelishomi RB, Ejtemaeemehr S, Tavangar SM, Rahimian R, Mobarakeh JI, Dehpour AR. Morphine is protective against doxorubicin-induced cardiotoxicity in rat. Toxicology 2008;243:96-104. [DOI:10.1016/j.tox.2007.09.026]
16. Dragojević-Simić V, Dobrić S, Jaćević V, Bokonjić D, Milosavljević I, Kovačević A, et al. Efficacy of amifostine in protection against doxorubicin-induced acute cardiotoxic effects in rats. Vojnosanit Pregl 2013;70:38-45. [DOI:10.2298/VSP110905041D]
17. Xu M, Sheng L, Zhu X, Zeng S, Chi D, Zhang GJ. Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats. Tumori 2010;96:460-4. [DOI:10.1177/030089161009600314]
18. Lakhanpal P, Rai DK. Quercetin: a versatile flavonoid. IJMU 2007;2:22-37. [DOI:10.4314/ijmu.v2i2.39851]
19. Abo‐Salem OM, Abd‐Ellah MF, Ghonaim MM. Hepatoprotective activity of quercetin against acrylonitrile‐induced hepatotoxicity in rats. J Biochem Mol Toxicol 2011;25:386-92. [DOI:10.1002/jbt.20406]
20. Baluchnejadmojarad T, Roghani M, Homayounfar H. Inhibitory effect of high dose of the flavonoid quercetin on amygdala electrical kindling in rats. Basic Clin Neurosci 2010;1:57-61.
21. Inal M, Altinişik M, Bilgin MD. The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct 2002;20:291-6. [DOI:10.1002/cbf.953]
22. Lee G, Luna HT, Editors. Manual of histologic staining methods of the armed forces institute of pathology. 3rd ed. New York: Mc Graw-Hill Book Company; 1988.p.32-107.
23. Ovesen L, Allingstrup L, Hannibal J, Mortensen EL, Hansen OP. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 1993;11:2043-9. [DOI:10.1200/JCO.1993.11.10.2043]
24. Mousavi Z, Hassanpourezatti M, Najafizadeh P, Rezagholian S, Rhamanifar MS, Nosrati N. Effects of Subcutaneous Injection MnO2 Micro-and Nanoparticles on Blood Glucose Level and Lipid Profile in Rat. Iran J Med Sci 2016;41:518-24.
25. Rašković A, Stilinović N, Kolarović J, Vasović V, Vukmirović S, Mikov M. The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules 2011;16:8601-13. [DOI:10.3390/molecules16108601]
26. Kahraman A, Çakar H, Köken T. The protective effect of quercetin on long-term alcohol consumption-induced oxidative stress. Mol Biol Rep 2012;39:2789-94. [DOI:10.1007/s11033-011-1037-2]
27. Khan SM. Protective effect of black tea extract on the levels of lipid peroxidation and antioxidant enzymes in liver of mice with pesticide‐induced liver injury. Cell Biochem Funct 2006;24:327-32. [DOI:10.1002/cbf.1246]
28. Coşkun Ö, Kanter M, Armutçu F, Çetin K, Kaybolmaz B, Yazgan Ö. Protective effects of quercetin, a flavonoid antioxidant, in absolute ethanol-induced acut gastric ulcer. Eur J Gen Med 2004;1:37-42. [DOI:10.29333/ejgm/82201]
29. Cui Y, Han Y, Yang X, Sun Y, Zhao Y. Protective effects of quercetin and quercetin-5', 8-disulfonate against carbon tetrachloride-caused oxidative liver injury in mice. Molecules 2013;19:291-305. [DOI:10.3390/molecules19010291]
30. Yousef MI, Omar SA, El-Guendi MI, Abdelmegid LA. Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food Chem Toxicol 2010;48:3246-61. [DOI:10.1016/j.fct.2010.08.034]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rahmani F, Asar N, Najafizadeh P, Mousavi S Z, Rastegar T. Cardioprotective effects of quercetin on doxorubicin induced cardiotoxicity in male rats. MEDICAL SCIENCES. 2018; 28 (1) :24-30
URL: http://iau-tmuj.ir/article-1-1369-en.html


Volume 28, Issue 1 (spring 2018) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.06 seconds with 31 queries by YEKTAWEB 3755